Weekly Vaccine Digest 3/17

County of Los Angeles, California sent this bulletin at 03/17/2023 03:15 PM PDT

Weekly Vaccine Digest 3/17

Los Angeles County Department of Public Health

Dear Colleagues and Partners,  

Below are the LACDPH weekly vaccine administration and order updates, upcoming webinars, and newsworthy events. Attached to this email you will find a pdf version of this digest.

If you received this email and would like to be added to our listserv, please contact our COVID-19 Provider Vaccine Call Center at covidvaccinereq@ph.lacounty.gov

Table of Contents

·         Page 1: Welcome, Order and Administration Reminders

·         Page 2: Ancillary Kits Expiry, CDC Recommendations, Moderna Monovalent

·         Page 3: Vaccine Marketplace Reminder, Upcoming/Past Webinars, Meetings and Resources

·         Page 4-5: LACDPH/CDPH Provider Office, Therapeutics

Order and Administration Reminders

  • REMINDER: Please place all orders in myCAvax by the Monday 3/20/23 5pm deadline. Ordering calendar and cadence can be found here. NOTE: Standard and small order functionality for the monovalent Moderna 12+ vaccine product have been shut-off in myCAvax.
  • REMINDER: Please report all COVID-19 doses administered within 24 hours to your medical record system and to CAIR as soon as practicable and no later than 72 hours.
  • REMINDER: Record Vaccine Waste in myCAvax. Job aid can be found here.
  • UPDATED: CDPH COVID-19 Provider Operations Manual can be found here.
  • UPDATED: Guide to Receiving Small Orders from the TPR can be found starting on page 79.
  • Temperature excursion worksheet can be found here.
  • CDPH COVID-19 Vaccine Timing Schedule can be found here.
  • CDC anaphylaxis job aid can be found here.
  • CDC coadministration resources can be found here.
  • COVID-19 Vaccine Product Guide can be found here.
  • CDC Guidance on Vaccine Administration Errors and Deviations can be found here.
  • CA COVID-19 Communication Toolkits can be found here.
  • Digital Vaccine Record Flyer can be found here.
  • Vaccine Expiry Checkers:

CDC Recommends Pfizer Infant/Toddler Bivalent COVID-19 Vaccine as Booster

  • Children 6 months through 4 years who completed a 3-dose Pfizer Infant/Toddler monovalent primary series are eligible for a booster dose at least two months after completion of their primary series.
  • Pfizer Infant/Toddler bivalent vaccine previously authorized/recommended as third dose of primary series
    • Children who received a primary series of 2 monovalent + 1 bivalent Pfizer Infant/Toddler vaccine are not currently eligible for Pfizer Infant/Toddler vaccine as a booster
  • FDA Press Release from 3/14/23 can be found  here.
  • UPDATED 3/16/23: Interim Clinical Consideration can be found here.

Moderna Monovalent COVID-19 Vaccine Expiry Talking Points

LADPH is no longer supporting requests for the monovalent Moderna 12+ vaccine product as there is no supply and all lots of this product will expire within two weeks. Standard and small order functionality for this product have been shut-off in myCAvax. There are no new safety concerns related to the Moderna monovalent vaccine and product discontinuation is normal as all vaccines have an expiration date. If you demonstrate a need for this product before the impending expiration, please send a message to covidvaccinereq@ph.lacounty.gov and we will continue to search for additional doses though this offer cannot be guaranteed.

Additional things to keep in mind related to the expiration of the monovalent Moderna 12+ vaccine product:

  • Per CDC recommendation, providers should not start a primary series with the Moderna 12+ vaccine product at this time, because the primary series cannot be completed with this product before it expires.
  • The Moderna updated bivalent vaccine may not be used as a primary series dose at this time, and it is unknown when it will be authorized or recommended.
  • This affects everyone 6 years and older who have received the first dose of Moderna for their primary series.
    • They can receive a second dose of Pfizer (if 6 years or older) or Novavax (if 12 years or older).
  • CDC guidance allows for mixing of vaccine brands if the original vaccine product is unavailable
  • The longest-dated Moderna monovalent vaccine is set to expire April 1, 2023
    • When the supplies run out or expire, there will be no more Moderna monovalent vaccine available.

_____________________________________________________________________________________

Ancillary Supply Kits Expiry

  • Do NOT discard the entire COVID-19 vaccine ancillary kit based on the date on the box’s ancillary kit label.
  • The expiration date printed on the box’s ancillary kit label does NOT apply to supplies with an expiration date printed on each item’s packaging.
    • Note: Expiration dates for masks and face shields are displayed on the ancillary supply kit label.
    • Check expiration dates for other supplies (needles, syringes, alcohol prep pads, diluent, etc.) on each items’ individual packaging.
  • Promptly discard of any expired items according to state and local regulations.
  • Old vaccine cards can be shredded
  • Excess ancillary supplies can be used for other non-COVID clinical activities
    • You can give them to other healthcare providers (within the U.S., only)

_____________________________________________________________________________________

Vaccine Marketplace Reminder

With products phasing out and expiring, this is a reminder that the Vaccine Marketplace is a great space for all providers to share & request doses of all vaccine types. For those who may need a refresher on what the marketplace is link here  or how to post, there is an interactive provider guide CDPH has released link here

_____________________________________________________________________________________

Upcoming/Past Meetings, Webinars, Calls and Resources

COVID 19 Crucial Conversations: Talking with Parents about COVID-19 Vaccines for Infants and Toddlers

  • Friday, 03/24/23, 12pm-1pm. Find registration link here

Novavax Office Hours

  • Registration for Novavax office hours from now through February can be found here

Pfizer COVID-19 Medical Updates and Trainings

  • Educational resources can be found here.

Moderna COVID-19 Vaccine Resources

  • Educational resources are available on Moderna’s website can be found here

Biweekly CDPH Quality Assurance Training Series

  • Mondays at 12pm, registration link can be found here

Biweekly myCAvax and MyTurn Office Hours

  • Registration link can be found here

CDC COCA Call: Evaluating and Supporting Children and Adolescents Presenting with Post-COVID Conditions

  • Slides can be found here.

CDC COCA Call: Clinical Guidance and Patient Education for Bivalent COVID-19 vaccines

  • Slides can be found here.

_____________________________________________________________________________________

LACDPH & CDPH Provider Office Hours Link

LA County Department of Public Health Provider Office Hours Information

  • Every other Wednesday from 9am-10am - Next meeting: 03/15/23
    • NOTE: Effective 2/01/23 the Office Hours will be held on a biweekly basis
  • This meeting has been combined with the Mpox Office Hours call. Part one of the meeting will focus on COVID-19 issues while the second part will address Mpox vaccine issues.
  • MS Teams meeting link below; please create a recurring calendar invite with this link.
  • To request meeting slides, please email covidvaccinereq@ph.lacounty.gov

Microsoft Teams meeting

Join on your computer or mobile app

Click here to join the meeting

Or call in (audio only)

+1 323-776-6996,,350547595#   United States, Los Angeles

Phone Conference ID: 350 547 595#

 

California Department of Public Health Provider Office Hours Registration Link

  • Every Friday from 9am-10:30am.
  • Complete one-time registration here.
  • Meeting recordings and slides can be found here.
  • Providers should add staff names to the Provider Listserv to receive weekly emails and updates. To be added, please email blanca.corona@cdph.ca.gov

_____________________________________________________________________________________

COVID-19 Therapeutics

  • Archived Webinar: Talking with Patients about COVID-19 Therapeutics
    • Alex McDonald provided an overview of COVID-19 therapeutics, myths and facts, and conversation tips to discuss treatment with patients.
    • Webinar slides can be found here and webinar recording can be found here.
  • Therapeutics Provider Warmline
    • Try the COVID-19 Therapeutics Warmline--UCSF's NCCC provides real-time, free clinical consultation by phone or online form. If you use the online form, you can expect a call back the same business day (or the next, if you submit close to 5 pm).
    • Health care providers and pharmacists can now call 1-866-268-4322 (COVID-CA) to receive free and confidential consultation on COVID-19 testing and treatment.
    • The COVID-19 Therapeutics Warmline is a real-time resource available to all California health care providers and is managed by the University of California, San Francisco (UCSF) National Clinician Consultation Center.
      • Health care providers of any experience level can call to speak with a clinician or pharmacist.
      • No PHI will be collected. Only basic provider contact and facility information.
      • An online case submission form will be available soon.
      • Available Monday through Friday, 6 am – 5 pm Voicemail messages left after hours will be returned on the next business day.
  • Update on Paxlovid Use in Pregnancy
    • The Society for Maternal-Fetal Medicine states it “supports the use of Paxlovid for treatment of pregnant patients with COVID-19 who meet clinical qualifications.”
    • The American College of Obstetricians and Gynecologists (ACOG) states pregnancy is “among the conditions that put individuals at high risk for clinical progression [to severe COVID]. This makes pregnant patients, including those with pregnancy as their only risk factor, eligible to receive outpatient oral SARS-CoV-2 protease inhibitor therapy [Paxlovid].”